Chelsea Diane Gawryletz DO
Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology
Physician
Join to view full profile
2121 E Harmony RdUnit 170Fort Collins, CO 80528
Phone+1 970-493-6337
Fax+1 970-493-3528
Dr. Gawryletz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2014 - 2017
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2011 - 2014
Arizona College of Osteopathic Medicine of Midwestern UniversityClass of 2011
University of Alaska FairbanksBS, Biochemistry and Molecular Biology, 2002 - 2006
Certifications & Licensure
CO State License 2018 - 2027
WY State License 2022 - 2027
NE State License 2022 - 2026
AZ State License 2011 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Security Audit Manager, Iatric Systems, Inc., 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2016-2017
Clinical Trials
- Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Start of enrollment: 2015 Oct 20
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles Start of enrollment: 2017 Apr 28
Publications & Presentations
PubMed
- 8 citationsMolecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholang...Jan B. Egan, David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos
JCO Precision Oncology. 2017-08-01 - 5 citationsCrucial considerations for pipelines to validate circulating biomarkers for breast cancer.Radwa Ewaisha, Chelsea D. Gawryletz, Karen S. Anderson
Expert Review of Proteomics. 2016-01-04 - 23 citationsSuccessful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitisJuan F. Gallegos-Orozco, CD Paskvan-Gawryletz, Gurudu, R Orenstein
Revista De Gastroenterologia De Mexico. 2012-01-01
Authored Content
- Ischemic Neuroprotection of Neuregulin-1 Response Cascade Involves the Ets Repressor FactorJune 2006
Press Mentions
- COVID-19 Vaccine Shows New Side Effect as It May Result in False Positive on MammogramsMarch 6th, 2021
Committees
- Co-chair, Hematology/Oncology curriculum committee 2018 - 2020
Research History
- Translational GenomicsBreast and Ovarian Cancer Research Unit (BOCRU) TGen, Helios Scholar 20082008 - 2018
- Biochemistry / molecular biology ResearchSpecialized Neuroscience Research Program (SNRP) graduate researcher, University of Alaska Fairbanks Chemistry Department2005 - 2007
- Research fellowMorehouse School of Medicine, National Institute of Health / National Institute of Neurological Disorders and Stroke.2005 - 2005
Professional Memberships
- Member
Industry Relationships
- Consultant, Seattle Genetics2020 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
